Selected research
Market Analysis & Forecast
Global Aquaporin Market Analysis and Forecast 2026-2032
Market perspective
The global Aquaporin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Aquaporin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Aquaporin include Merck KGaA, Santa Cruz Biotechnology, Proteintech Group, Boster Biological Technology, Bio-Techne, Bio-Rad Laboratories, Alomone Labs, Abcam and Abbexa, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Aquaporin, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Aquaporin, also provides the revenue of main regions and countries. Of the upcoming market potential for Aquaporin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Aquaporin revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Aquaporin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Aquaporin revenue, projected growth trends, production technology, application and end-user industry.
Aquaporin Segment by Company
Merck KGaA
Santa Cruz Biotechnology
Proteintech Group
Boster Biological Technology
Bio-Techne
Bio-Rad Laboratories
Alomone Labs
Abcam
Abbexa
Aquaporin Segment by Type
Anti-Aquaporin Antibody
Aquaporin Channel Blocker
Other
Aquaporin Segment by Application
Purification Of Water
Research
Medicine
Other
Aquaporin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aquaporin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Aquaporin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aquaporin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Aquaporin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Aquaporin company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Aquaporin revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Aquaporin Antibody
- Aquaporin Channel Blocker
- Other
Applications
- Purification Of Water
- Research
- Medicine
- Other
Companies covered
- Merck KGaA
- Santa Cruz Biotechnology
- Proteintech Group
- Boster Biological Technology
- Bio-Techne
- Bio-Rad Laboratories
- Alomone Labs
- Abcam
- Abbexa
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Aquaporin Market by Type
- 1.2.1 Global Aquaporin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Anti-Aquaporin Antibody
- 1.2.3 Aquaporin Channel Blocker
- 1.2.4 Other
- 1.3 Aquaporin Market by Application
- 1.3.1 Global Aquaporin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Purification Of Water
- 1.3.3 Research
- 1.3.4 Medicine
- 1.3.5 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Aquaporin Market Dynamics
- 2.1 Aquaporin Industry Trends
- 2.2 Aquaporin Industry Drivers
- 2.3 Aquaporin Industry Opportunities and Challenges
- 2.4 Aquaporin Industry Restraints
3 Global Growth Perspective
- 3.1 Global Aquaporin Market Perspective (2021-2032)
- 3.2 Global Aquaporin Growth Trends by Region
- 3.2.1 Global Aquaporin Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Aquaporin Market Size by Region (2021-2026)
- 3.2.3 Global Aquaporin Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Aquaporin Revenue by Players
- 4.1.1 Global Aquaporin Revenue by Players (2021-2026)
- 4.1.2 Global Aquaporin Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Aquaporin Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Aquaporin Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Aquaporin Key Players Headquarters & Area Served
- 4.4 Global Aquaporin Players, Product Type & Application
- 4.5 Global Aquaporin Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Aquaporin Market CR5 and HHI
- 4.6.3 2025 Aquaporin Tier 1, Tier 2, and Tier 3
5 Aquaporin Market Size by Type
- 5.1 Global Aquaporin Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Aquaporin Revenue by Type (2021-2032)
- 5.3 Global Aquaporin Revenue Market Share by Type (2021-2032)
6 Aquaporin Market Size by Application
- 6.1 Global Aquaporin Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Aquaporin Revenue by Application (2021-2032)
- 6.3 Global Aquaporin Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Merck KGaA
- 7.1.1 Merck KGaA Company Information
- 7.1.2 Merck KGaA Business Overview
- 7.1.3 Merck KGaA Aquaporin Revenue and Gross Margin (2021-2026)
- 7.1.4 Merck KGaA Aquaporin Product Portfolio
- 7.1.5 Merck KGaA Recent Developments
- 7.2 Santa Cruz Biotechnology
- 7.2.1 Santa Cruz Biotechnology Company Information
- 7.2.2 Santa Cruz Biotechnology Business Overview
- 7.2.3 Santa Cruz Biotechnology Aquaporin Revenue and Gross Margin (2021-2026)
- 7.2.4 Santa Cruz Biotechnology Aquaporin Product Portfolio
- 7.2.5 Santa Cruz Biotechnology Recent Developments
- 7.3 Proteintech Group
- 7.3.1 Proteintech Group Company Information
- 7.3.2 Proteintech Group Business Overview
- 7.3.3 Proteintech Group Aquaporin Revenue and Gross Margin (2021-2026)
- 7.3.4 Proteintech Group Aquaporin Product Portfolio
- 7.3.5 Proteintech Group Recent Developments
- 7.4 Boster Biological Technology
- 7.4.1 Boster Biological Technology Company Information
- 7.4.2 Boster Biological Technology Business Overview
- 7.4.3 Boster Biological Technology Aquaporin Revenue and Gross Margin (2021-2026)
- 7.4.4 Boster Biological Technology Aquaporin Product Portfolio
- 7.4.5 Boster Biological Technology Recent Developments
- 7.5 Bio-Techne
- 7.5.1 Bio-Techne Company Information
- 7.5.2 Bio-Techne Business Overview
- 7.5.3 Bio-Techne Aquaporin Revenue and Gross Margin (2021-2026)
- 7.5.4 Bio-Techne Aquaporin Product Portfolio
- 7.5.5 Bio-Techne Recent Developments
- 7.6 Bio-Rad Laboratories
- 7.6.1 Bio-Rad Laboratories Company Information
- 7.6.2 Bio-Rad Laboratories Business Overview
- 7.6.3 Bio-Rad Laboratories Aquaporin Revenue and Gross Margin (2021-2026)
- 7.6.4 Bio-Rad Laboratories Aquaporin Product Portfolio
- 7.6.5 Bio-Rad Laboratories Recent Developments
- 7.7 Alomone Labs
- 7.7.1 Alomone Labs Company Information
- 7.7.2 Alomone Labs Business Overview
- 7.7.3 Alomone Labs Aquaporin Revenue and Gross Margin (2021-2026)
- 7.7.4 Alomone Labs Aquaporin Product Portfolio
- 7.7.5 Alomone Labs Recent Developments
- 7.8 Abcam
- 7.8.1 Abcam Company Information
- 7.8.2 Abcam Business Overview
- 7.8.3 Abcam Aquaporin Revenue and Gross Margin (2021-2026)
- 7.8.4 Abcam Aquaporin Product Portfolio
- 7.8.5 Abcam Recent Developments
- 7.9 Abbexa
- 7.9.1 Abbexa Company Information
- 7.9.2 Abbexa Business Overview
- 7.9.3 Abbexa Aquaporin Revenue and Gross Margin (2021-2026)
- 7.9.4 Abbexa Aquaporin Product Portfolio
- 7.9.5 Abbexa Recent Developments
8 North America
- 8.1 North America Aquaporin Revenue (2021-2032)
- 8.2 North America Aquaporin Revenue by Type (2021-2032)
- 8.2.1 North America Aquaporin Revenue by Type (2021-2026)
- 8.2.2 North America Aquaporin Revenue by Type (2027-2032)
- 8.3 North America Aquaporin Revenue Share by Type (2021-2032)
- 8.4 North America Aquaporin Revenue by Application (2021-2032)
- 8.4.1 North America Aquaporin Revenue by Application (2021-2026)
- 8.4.2 North America Aquaporin Revenue by Application (2027-2032)
- 8.5 North America Aquaporin Revenue Share by Application (2021-2032)
- 8.6 North America Aquaporin Revenue by Country
- 8.6.1 North America Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Aquaporin Revenue by Country (2021-2026)
- 8.6.3 North America Aquaporin Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
9 Europe
- 9.1 Europe Aquaporin Revenue (2021-2032)
- 9.2 Europe Aquaporin Revenue by Type (2021-2032)
- 9.2.1 Europe Aquaporin Revenue by Type (2021-2026)
- 9.2.2 Europe Aquaporin Revenue by Type (2027-2032)
- 9.3 Europe Aquaporin Revenue Share by Type (2021-2032)
- 9.4 Europe Aquaporin Revenue by Application (2021-2032)
- 9.4.1 Europe Aquaporin Revenue by Application (2021-2026)
- 9.4.2 Europe Aquaporin Revenue by Application (2027-2032)
- 9.5 Europe Aquaporin Revenue Share by Application (2021-2032)
- 9.6 Europe Aquaporin Revenue by Country
- 9.6.1 Europe Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Aquaporin Revenue by Country (2021-2026)
- 9.6.3 Europe Aquaporin Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Netherlands
10 China
- 10.1 China Aquaporin Revenue (2021-2032)
- 10.2 China Aquaporin Revenue by Type (2021-2032)
- 10.2.1 China Aquaporin Revenue by Type (2021-2026)
- 10.2.2 China Aquaporin Revenue by Type (2027-2032)
- 10.3 China Aquaporin Revenue Share by Type (2021-2032)
- 10.4 China Aquaporin Revenue by Application (2021-2032)
- 10.4.1 China Aquaporin Revenue by Application (2021-2026)
- 10.4.2 China Aquaporin Revenue by Application (2027-2032)
- 10.5 China Aquaporin Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Aquaporin Revenue (2021-2032)
- 11.2 Asia Aquaporin Revenue by Type (2021-2032)
- 11.2.1 Asia Aquaporin Revenue by Type (2021-2026)
- 11.2.2 Asia Aquaporin Revenue by Type (2027-2032)
- 11.3 Asia Aquaporin Revenue Share by Type (2021-2032)
- 11.4 Asia Aquaporin Revenue by Application (2021-2032)
- 11.4.1 Asia Aquaporin Revenue by Application (2021-2026)
- 11.4.2 Asia Aquaporin Revenue by Application (2027-2032)
- 11.5 Asia Aquaporin Revenue Share by Application (2021-2032)
- 11.6 Asia Aquaporin Revenue by Country
- 11.6.1 Asia Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Aquaporin Revenue by Country (2021-2026)
- 11.6.3 Asia Aquaporin Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Aquaporin Revenue (2021-2032)
- 12.2 SAMEA Aquaporin Revenue by Type (2021-2032)
- 12.2.1 SAMEA Aquaporin Revenue by Type (2021-2026)
- 12.2.2 SAMEA Aquaporin Revenue by Type (2027-2032)
- 12.3 SAMEA Aquaporin Revenue Share by Type (2021-2032)
- 12.4 SAMEA Aquaporin Revenue by Application (2021-2032)
- 12.4.1 SAMEA Aquaporin Revenue by Application (2021-2026)
- 12.4.2 SAMEA Aquaporin Revenue by Application (2027-2032)
- 12.5 SAMEA Aquaporin Revenue Share by Application (2021-2032)
- 12.6 SAMEA Aquaporin Revenue by Country
- 12.6.1 SAMEA Aquaporin Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Aquaporin Revenue by Country (2021-2026)
- 12.6.3 SAMEA Aquaporin Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst